SCHEMBL9595239

SCHEMBL9595239

Cc1cc2nc3cc(C)c(C)cc3c(Cl)c2cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.45
▸ KDM4E B2RXH2 4/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ RAD52 P43351 1/20 0.44
▸ QRFPR Q96P65 1/20 0.44
▸ MAOA P21397 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ PDE3B Q13370 2/20 0.40
▸ PDE3A Q14432 2/20 0.40
▸ MAPT P10636 3/20 0.39
▸ CYP1A2 P05177 2/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ GAA P10253 1/20 0.37
▸ MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9593843 0.86 LMNA (0.53) NQO2ALDH1A1KDM4ESMN1; SMN2RAD52
SCHEMBL9593890 0.84 NQO2 (0.47) NQO2ALDH1A1KDM4ESMN1; SMN2RAB9A
SCHEMBL9593499 0.84 PDE3B (0.46) NQO2ALDH1A1KDM4ESMN1; SMN2RAB9A
SCHEMBL9594269 0.84 NQO2 (0.47) NQO2ALDH1A1KDM4ESMN1; SMN2RAB9A
SCHEMBL9593780 0.80 POLB (0.51) NQO2ALDH1A1KDM4ESMN1; SMN2RAB9A
SCHEMBL9593472 0.80 MPO (0.47) NQO2ALDH1A1KDM4ESMN1; SMN2RAB9A
SCHEMBL9594784 0.76 PDE3B (0.46) NQO2ALDH1A1KDM4ESMN1; SMN2RAB9A
SCHEMBL9593886 0.76 PDE3B (0.46) NQO2ALDH1A1KDM4ESMN1; SMN2RAB9A
SCHEMBL9724203 0.75 MAPT (0.63) NQO2ALDH1A1KDM4ESMN1; SMN2RAB9A
SCHEMBL8139053 0.75 ALDH1A1 (0.41) NQO2ALDH1A1KDM4ESMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1991005770-A1 POTENTIAL ANTICANCER AGENTS DERIVED FROM ACRIDINE SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1991-05-02 — — WO claimed
US-5229395-A Potential anticancer agents derived from acridine SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1993-07-20 — — US disclosed
WO-1991005770-A1 POTENTIAL ANTICANCER AGENTS DERIVED FROM ACRIDINE SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1991-05-02 — — WO disclosed
Send feedback